Zenovel provides flexible contract staffing and recruiting options for global CROs and pharmaceutical firms, offering Full-Time Equivalent (FTE) models with experienced CRAs and Auditors from over 30 countries. These models enable customized staffing solutions for specific time periods and requirements related to studies or assignments. Zenovel provides flexibility of 0.5 FTE to 1 FTE for a specific time duration (e.g., 3 months) and for a specific study or assignment.
FTE is offered for various roles including CRA, CTA, CRC, Project Manager, Data Management, Medical & Scientific Writing, Biometrics, and more.
Contact us today to learn more about how Zenovel’s flexible staffing services can meet your staffing needs effectively and efficiently.
At Zenovel, our contract staffing solutions are designed to seamlessly integrate with your broader quality and compliance framework, supporting sponsors and CROs across all stages of clinical research operations. Our experienced professionals work in alignment with Zenovel’s GCP compliance and oversight services to ensure consistency, accountability, and regulatory readiness, while adhering to global expectations outlined by regulatory authorities such as the FDA and ICH-GCP guidelines. This integrated approach enables organizations to scale resources efficiently without compromising data integrity, inspection preparedness, or study quality.
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk-Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data, and
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.
